These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6160109)

  • 1. Interferon in experimental viral infections in mice: tissue interferon levels resulting from the virus infection and from exogenous interferon therapy.
    Heremans H; Billiau A; De Somer P
    Infect Immun; 1980 Nov; 30(2):513-22. PubMed ID: 6160109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mediators of protection against lethal systemic vesicular stomatitis virus infection in hamsters: defective interfering particles, polyinosinate-polycytidylate, and interferon.
    Fultz PN; Shadduck JA; Kang CY; Streilein JW
    Infect Immun; 1982 Aug; 37(2):679-86. PubMed ID: 6180986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral activity of a thymic factor in experimental viral infections. I. Thymic hormonal effect on survival, interferon production and NK cell activity in Mengo virus-infected mice.
    Klein AS; Fixler R; Shoham J
    J Immunol; 1984 Jun; 132(6):3159-63. PubMed ID: 6202776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of rabbits against local vaccinia virus infection by Brucella abortus and polyacrylic acid in the absence of systemic interferon production.
    De Clercq E; De Somer P
    Infect Immun; 1973 Oct; 8(4):669-73. PubMed ID: 4355140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further studies on the relative antiviral efficacies of interferons induced by poly I:C and Mengo virus.
    Campbell JB
    Can J Microbiol; 1976 May; 22(5):712-8. PubMed ID: 179687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-gamma interferon-treated mice.
    Leist TP; Eppler M; Zinkernagel RM
    J Virol; 1989 Jun; 63(6):2813-9. PubMed ID: 2542591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-inducing polycarboxylates: mechanism of protection against vaccinia virus infection in mice.
    Billiau A; Muyembe JJ; De Somer P
    Infect Immun; 1972 Jun; 5(6):854-7. PubMed ID: 4344092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity in mice of temperature-sensitive mutants of vesicular stomatitis virus: early appearance in bronchial secretions of an interferon-like inhibitor.
    Beatrice ST; Wagner RR
    J Gen Virol; 1980 Apr; 47(2):529-33. PubMed ID: 6154132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat interferons. VI. Heterologous interferon in the treatment of viral infections.
    Lobodzińska M; Albin M
    Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):247-52. PubMed ID: 220932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CIRCULATING INTERFERON IN MICE AFTER INTRAVENOUS INJECTION OF VIRUS.
    BARON S; BUCKLER CE
    Science; 1963 Sep; 141(3585):1061-3. PubMed ID: 14043352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon response in the guinea pig infected with Junín virus.
    Dejean CB; Ayerra BL; Teyssié AR
    J Med Virol; 1987 Sep; 23(1):83-91. PubMed ID: 2445908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on experimental vaccinia virus infection in mice with special reference to host defence mechanisms.
    Prasad CB; Hedström KG
    Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):97-111. PubMed ID: 4377639
    [No Abstract]   [Full Text] [Related]  

  • 13. Murine infection by vesicular stomatitis virus: initial characterization of the H-2d system.
    Forger JM; Bronson RT; Huang AS; Reiss CS
    J Virol; 1991 Sep; 65(9):4950-8. PubMed ID: 1651414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postchallenge administration of brincidofovir protects healthy and immune-deficient mice reconstituted with limited numbers of T cells from lethal challenge with IHD-J-Luc vaccinia virus.
    Zaitseva M; McCullough KT; Cruz S; Thomas A; Diaz CG; Keilholz L; Grossi IM; Trost LC; Golding H
    J Virol; 2015 Mar; 89(6):3295-307. PubMed ID: 25589648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections.
    Selin LK; Vergilis K; Welsh RM; Nahill SR
    J Exp Med; 1996 Jun; 183(6):2489-99. PubMed ID: 8676069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of interferon in the protective effect of a synthetic double-stranded polyribonucleotide against intranasal vesicular stomatitis virus challenge in mice.
    De Clercq E; Nuwer MR; Merigan TC
    J Clin Invest; 1970 Aug; 49(8):1565-77. PubMed ID: 4317283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of effect of interferon aerosol prophylaxis of vesicular stomatitis virus infection in mice.
    Wyde PR; Sun CS; Wilson SZ; Knight V
    Antimicrob Agents Chemother; 1985 Jan; 27(1):60-4. PubMed ID: 2984982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice.
    Huneycutt BS; Bi Z; Aoki CJ; Reiss CS
    J Virol; 1993 Nov; 67(11):6698-706. PubMed ID: 8105106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstitution with T lymphocytes protects nude mice from a central nervous system disorder induced by a temperature-sensitive vesicular stomatitis virus.
    Doll SC; Johnson TC
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():1969-77. PubMed ID: 2841409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral activity of chlorite-oxidized oxyamylose, a polyacetal carboxylic acid.
    Billiau A; Desmyter J; De Somer P
    J Virol; 1970 Mar; 5(3):321-8. PubMed ID: 4314554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.